SPDR S&P Pharmaceuticals ETF $XPH Shares Purchased by UBS Group AG

UBS Group AG increased its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 33.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,961 shares of the company’s stock after purchasing an additional 11,948 shares during the period. UBS Group AG owned 1.02% of SPDR S&P Pharmaceuticals ETF worth $2,686,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Envestnet Asset Management Inc. acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the third quarter worth $10,732,000. Goldman Sachs Group Inc. grew its stake in shares of SPDR S&P Pharmaceuticals ETF by 96.9% during the first quarter. Goldman Sachs Group Inc. now owns 119,929 shares of the company’s stock worth $5,253,000 after purchasing an additional 59,007 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of SPDR S&P Pharmaceuticals ETF by 2.5% during the third quarter. JPMorgan Chase & Co. now owns 58,699 shares of the company’s stock worth $2,814,000 after purchasing an additional 1,441 shares in the last quarter. Clark Capital Management Group Inc. acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the third quarter worth $2,248,000. Finally, SVB Wealth LLC grew its stake in shares of SPDR S&P Pharmaceuticals ETF by 1.7% during the third quarter. SVB Wealth LLC now owns 41,689 shares of the company’s stock worth $1,999,000 after purchasing an additional 677 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Price Performance

NYSEARCA XPH opened at $58.08 on Wednesday. SPDR S&P Pharmaceuticals ETF has a 1 year low of $40.01 and a 1 year high of $60.73. The company has a market capitalization of $357.19 million, a PE ratio of 14.28 and a beta of 0.61. The company has a fifty day moving average of $56.32 and a two-hundred day moving average of $55.72.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.